According to BIO's Jim Greenwood, one proposal released by Hillary Clinton's campaign "would do irreparable harm to the nation’s health innovation system." Consequences cited included "significantly" hindering emerging biotech companies from developing new cures/therapies needed by patients. Railing against "intrusive government regulation," Greenwood cited past bipartisan rebuffs of provisions of Clinton's plan and said results would include fewer medicines and restricted access to them.